$MDCO Insider Trading
FREE EMAIL WATCHDOG
Get free email notifications about insider trading in MEDICINES CO /DE.
- Your email is safe with us.
- The service is free and you can unsubscribe at any time.
General | Insiders | Insider Transactions | Monthly Overview | Weekly Overview
Overview of all insider trading transactions in MEDICINES CO /DE. Get notifications about new insider transactions in MEDICINES CO /DE for free.
Page: < prev 1 ... 3 4 5 6 7 8 9 10 11 ... 13 next >
| Date | Ticker | Company | Owner | Relationship | Transaction | Code | Cost ($) | Shares | Transaction Value ($) | Total Shares | % Holdings |
|---|---|---|---|---|---|---|---|---|---|---|---|
| May 24 2012 | MDCO | MEDICINES CO /DE | CROUSE WILLIAM | Director | Option Exercise | A | 0.00 | 12,039 | 0 | 12,039 | |
| May 24 2012 | MDCO | MEDICINES CO /DE | CROUSE WILLIAM | Director | Grant | A | 0.00 | 5,086 | 0 | 26,000 | 20.9 K to 26 K (+24.32 %) |
| May 24 2012 | MDCO | MEDICINES CO /DE | Savage Robert G. | Director | Option Exercise | A | 21.14 | 12,039 | 254,504 | 12,039 | |
| May 24 2012 | MDCO | MEDICINES CO /DE | Savage Robert G. | Director | Grant | A | 0.00 | 5,086 | 0 | 26,000 | 20.9 K to 26 K (+24.32 %) |
| May 24 2012 | MDCO | MEDICINES CO /DE | Spigelman Melvin K | Director | Option Exercise | A | 21.14 | 12,039 | 254,504 | 12,039 | |
| May 24 2012 | MDCO | MEDICINES CO /DE | Spigelman Melvin K | Director | Grant | A | 0.00 | 5,086 | 0 | 26,000 | 20.9 K to 26 K (+24.32 %) |
| May 24 2012 | MDCO | MEDICINES CO /DE | HUGIN ROBERT J | Director | Option Exercise | A | 21.14 | 12,039 | 254,504 | 12,039 | |
| May 24 2012 | MDCO | MEDICINES CO /DE | HUGIN ROBERT J | Director | Grant | A | 0.00 | 5,086 | 0 | 44,333 | 39.2 K to 44.3 K (+12.96 %) |
| May 03 2012 | MDCO | MEDICINES CO /DE | MEANWELL CLIVE | Chairman & CEO | Sell | S | 22.16 | 5,000 | 110,800 | 365,300 | 370.3 K to 365.3 K (-1.35 %) |
| May 03 2012 | MDCO | MEDICINES CO /DE | Kelly John C. | Director | Buy | P | 21.90 | 9,150 | 200,385 | 15,064 | 5.9 K to 15.1 K (+154.72 %) |
| Apr 27 2012 | MDCO | MEDICINES CO /DE | Shigeta Hiroaki | Director | Option Exercise | M | 8.28 | 12,500 | 103,500 | 0 | |
| Apr 27 2012 | MDCO | MEDICINES CO /DE | Shigeta Hiroaki | Director | Option Exercise | M | 7.51 | 7,500 | 56,325 | 0 | |
| Apr 27 2012 | MDCO | MEDICINES CO /DE | Shigeta Hiroaki | Director | Sell | S | 21.50 | 27,500 | 591,250 | 13,414 | 40.9 K to 13.4 K (-67.21 %) |
| Apr 27 2012 | MDCO | MEDICINES CO /DE | Shigeta Hiroaki | Director | Buy | M | 8.28 | 12,500 | 103,500 | 40,914 | 28.4 K to 40.9 K (+43.99 %) |
| Apr 27 2012 | MDCO | MEDICINES CO /DE | Shigeta Hiroaki | Director | Buy | M | 7.51 | 7,500 | 56,325 | 28,414 | 20.9 K to 28.4 K (+35.86 %) |
| Apr 18 2012 | MDCO | MEDICINES CO /DE | Antinori Paul Michael | Sr. VP & General Co ... | Option Exercise | M | 9.13 | 18,750 | 171,188 | 0 | |
| Apr 18 2012 | MDCO | MEDICINES CO /DE | Antinori Paul Michael | Sr. VP & General Co ... | Buy | M | 9.13 | 18,750 | 171,188 | 62,157 | 43.4 K to 62.2 K (+43.20 %) |
| Apr 04 2012 | MDCO | MEDICINES CO /DE | MEANWELL CLIVE | Chairman & CEO | Sell | S | 20.07 | 5,000 | 100,350 | 370,300 | 375.3 K to 370.3 K (-1.33 %) |
| Mar 05 2012 | MDCO | MEDICINES CO /DE | MEANWELL CLIVE | Chairman & CEO | Sell | S | 21.49 | 5,000 | 107,450 | 375,300 | 380.3 K to 375.3 K (-1.31 %) |
| Mar 05 2012 | MDCO | MEDICINES CO /DE | MEANWELL CLIVE | Chairman & CEO | Buy | J | 12.03 | 883 | 10,622 | 380,300 | 379.4 K to 380.3 K (+0.23 %) |
| Mar 15 2012 | MDCO | MEDICINES CO /DE | KESSLER ARMIN M | Director | Option Exercise | M | 8.51 | 7,500 | 63,825 | 0 | |
| Mar 15 2012 | MDCO | MEDICINES CO /DE | KESSLER ARMIN M | Director | Buy | M | 8.51 | 7,500 | 63,825 | 117,099 | 109.6 K to 117.1 K (+6.84 %) |
| Mar 21 2012 | MDCO | MEDICINES CO /DE | SBLENDORIO GLENN | President & CFO | Option Exercise | M | 7.31 | 625 | 4,569 | 15,625 | |
| Mar 21 2012 | MDCO | MEDICINES CO /DE | SBLENDORIO GLENN | President & CFO | Sell | S | 20.39 | 625 | 12,744 | 105,866 | 106.5 K to 105.9 K (-0.59 %) |
| Mar 21 2012 | MDCO | MEDICINES CO /DE | SBLENDORIO GLENN | President & CFO | Buy | M | 7.31 | 625 | 4,569 | 106,491 | 105.9 K to 106.5 K (+0.59 %) |
| Feb 28 2012 | MDCO | MEDICINES CO /DE | SBLENDORIO GLENN | President & CFO | Option Exercise | A | 22.04 | 68,000 | 1,498,720 | 68,000 | |
| Feb 28 2012 | MDCO | MEDICINES CO /DE | SBLENDORIO GLENN | President & CFO | Grant | A | 22.04 | 42,500 | 936,700 | 104,983 | 62.5 K to 105 K (+68.02 %) |
| Mar 15 2012 | MDCO | MEDICINES CO /DE | O'Connor William Bernard | Chief Accounting Of ... | Sell | S | 21.08 | 1,040 | 21,923 | 21,933 | 23 K to 21.9 K (-4.53 %) |
| Mar 05 2012 | MDCO | MEDICINES CO /DE | Antinori Paul Michael | Sr. VP & General Co ... | Buy | J | 12.03 | 314 | 3,777 | 43,407 | 43.1 K to 43.4 K (+0.73 %) |
| Mar 05 2012 | MDCO | MEDICINES CO /DE | SBLENDORIO GLENN | President & CFO | Buy | J | 12.03 | 883 | 10,622 | 105,866 | 105 K to 105.9 K (+0.84 %) |
| Feb 28 2012 | MDCO | MEDICINES CO /DE | O'Connor William Bernard | Chief Accounting Of ... | Option Exercise | A | 22.04 | 20,000 | 440,800 | 20,000 | |
| Feb 28 2012 | MDCO | MEDICINES CO /DE | O'Connor William Bernard | Chief Accounting Of ... | Grant | A | 22.04 | 12,500 | 275,500 | 22,973 | 10.5 K to 23 K (+119.35 %) |
| Feb 28 2012 | MDCO | MEDICINES CO /DE | Antinori Paul Michael | Sr. VP & General Co ... | Option Exercise | A | 22.04 | 20,000 | 440,800 | 20,000 | |
| Feb 28 2012 | MDCO | MEDICINES CO /DE | Antinori Paul Michael | Sr. VP & General Co ... | Grant | A | 22.04 | 12,500 | 275,500 | 43,093 | 30.6 K to 43.1 K (+40.86 %) |
| Feb 28 2012 | MDCO | MEDICINES CO /DE | MEANWELL CLIVE | Chairman & CEO | Option Exercise | A | 22.04 | 150,000 | 3,306,000 | 150,000 | |
| Feb 28 2012 | MDCO | MEDICINES CO /DE | MEANWELL CLIVE | Chairman & CEO | Grant | A | 22.04 | 93,750 | 2,066,250 | 379,417 | 285.7 K to 379.4 K (+32.82 %) |
| Feb 27 2012 | MDCO | MEDICINES CO /DE | O'Connor William Bernard | Chief Accounting Of ... | Sell | S | 22.22 | 1,908 | 42,396 | 10,473 | 12.4 K to 10.5 K (-15.41 %) |
| Feb 23 2012 | MDCO | MEDICINES CO /DE | Antinori Paul Michael | Sr. VP & General Co ... | Sell | S | 20.94 | 1,008 | 21,108 | 30,593 | 31.6 K to 30.6 K (-3.19 %) |
| Feb 23 2012 | MDCO | MEDICINES CO /DE | Antinori Paul Michael | Sr. VP & General Co ... | Sell | S | 20.94 | 348 | 7,287 | 31,601 | 31.9 K to 31.6 K (-1.09 %) |
| Feb 23 2012 | MDCO | MEDICINES CO /DE | Antinori Paul Michael | Sr. VP & General Co ... | Sell | S | 20.94 | 223 | 4,670 | 31,949 | 32.2 K to 31.9 K (-0.69 %) |
| Feb 23 2012 | MDCO | MEDICINES CO /DE | Rohrbacker Leslie C | VP, Chief Human Str ... | Sell | S | 20.94 | 335 | 7,015 | 13,628 | 14 K to 13.6 K (-2.40 %) |
| Feb 23 2012 | MDCO | MEDICINES CO /DE | Rohrbacker Leslie C | VP, Chief Human Str ... | Sell | S | 20.94 | 548 | 11,475 | 13,963 | 14.5 K to 14 K (-3.78 %) |
| Feb 23 2012 | MDCO | MEDICINES CO /DE | Rohrbacker Leslie C | VP, Chief Human Str ... | Sell | S | 20.94 | 627 | 13,129 | 14,511 | 15.1 K to 14.5 K (-4.14 %) |
| Feb 23 2012 | MDCO | MEDICINES CO /DE | O'Connor William Bernard | Chief Accounting Of ... | Sell | S | 20.94 | 519 | 10,868 | 12,381 | 12.9 K to 12.4 K (-4.02 %) |
| Feb 23 2012 | MDCO | MEDICINES CO /DE | O'Connor William Bernard | Chief Accounting Of ... | Sell | S | 20.94 | 548 | 11,475 | 12,900 | 13.4 K to 12.9 K (-4.07 %) |
| Feb 23 2012 | MDCO | MEDICINES CO /DE | O'Connor William Bernard | Chief Accounting Of ... | Sell | S | 20.94 | 627 | 13,129 | 13,448 | 14.1 K to 13.4 K (-4.45 %) |
| Feb 23 2012 | MDCO | MEDICINES CO /DE | MEANWELL CLIVE | Chairman & CEO | Sell | S | 20.94 | 7,063 | 147,899 | 285,667 | 292.7 K to 285.7 K (-2.41 %) |
| Feb 23 2012 | MDCO | MEDICINES CO /DE | MEANWELL CLIVE | Chairman & CEO | Sell | S | 20.94 | 1,842 | 38,571 | 292,730 | 294.6 K to 292.7 K (-0.63 %) |
| Feb 23 2012 | MDCO | MEDICINES CO /DE | MEANWELL CLIVE | Chairman & CEO | Sell | S | 20.94 | 4,425 | 92,660 | 294,572 | 299 K to 294.6 K (-1.48 %) |
| Feb 23 2012 | MDCO | MEDICINES CO /DE | SBLENDORIO GLENN | Executive VP & CFO | Option Exercise | M | 7.31 | 625 | 4,569 | 16,250 | |
| Feb 23 2012 | MDCO | MEDICINES CO /DE | SBLENDORIO GLENN | Executive VP & CFO | Sell | S | 21.03 | 625 | 13,144 | 62,483 | 63.1 K to 62.5 K (-0.99 %) |
| Feb 23 2012 | MDCO | MEDICINES CO /DE | SBLENDORIO GLENN | Executive VP & CFO | Buy | M | 7.31 | 625 | 4,569 | 63,108 | 62.5 K to 63.1 K (+1.00 %) |
| Feb 23 2012 | MDCO | MEDICINES CO /DE | SBLENDORIO GLENN | Executive VP & CFO | Sell | S | 20.94 | 1,781 | 37,294 | 62,483 | 64.3 K to 62.5 K (-2.77 %) |
| Feb 23 2012 | MDCO | MEDICINES CO /DE | SBLENDORIO GLENN | Executive VP & CFO | Sell | S | 20.94 | 833 | 17,443 | 64,264 | 65.1 K to 64.3 K (-1.28 %) |
| Feb 23 2012 | MDCO | MEDICINES CO /DE | SBLENDORIO GLENN | Executive VP & CFO | Sell | S | 20.94 | 1,505 | 31,515 | 65,097 | 66.6 K to 65.1 K (-2.26 %) |
| Feb 16 2012 | MDCO | MEDICINES CO /DE | Antinori Paul Michael | Sr. VP & General Co ... | Sell | S | 20.89 | 500 | 10,445 | 32,172 | 32.7 K to 32.2 K (-1.53 %) |
| Feb 02 2012 | MDCO | MEDICINES CO /DE | MEANWELL CLIVE | Chairman & CEO | Sell | S | 20.08 | 5,000 | 100,400 | 298,997 | 304 K to 299 K (-1.64 %) |
| Feb 02 2012 | MDCO | MEDICINES CO /DE | MEANWELL CLIVE | Chairman & CEO | Sell | S | 20.00 | 2,500 | 50,000 | 303,997 | 306.5 K to 304 K (-0.82 %) |
| Feb 07 2012 | MDCO | MEDICINES CO /DE | Antinori Paul Michael | Sr. VP & General Co ... | Option Exercise | M | 9.13 | 5,000 | 45,650 | 18,750 | |
| Feb 07 2012 | MDCO | MEDICINES CO /DE | Antinori Paul Michael | Sr. VP & General Co ... | Sell | S | 22.00 | 5,000 | 110,000 | 32,672 | 37.7 K to 32.7 K (-13.27 %) |
| Feb 07 2012 | MDCO | MEDICINES CO /DE | Antinori Paul Michael | Sr. VP & General Co ... | Buy | M | 9.13 | 5,000 | 45,650 | 37,672 | 32.7 K to 37.7 K (+15.30 %) |
| Jan 20 2012 | MDCO | MEDICINES CO /DE | SBLENDORIO GLENN | Executive VP & CFO | Option Exercise | M | 7.31 | 625 | 4,569 | 16,875 | |
| Jan 20 2012 | MDCO | MEDICINES CO /DE | SBLENDORIO GLENN | Executive VP & CFO | Sell | S | 19.38 | 625 | 12,113 | 66,602 | 67.2 K to 66.6 K (-0.93 %) |
| Jan 20 2012 | MDCO | MEDICINES CO /DE | SBLENDORIO GLENN | Executive VP & CFO | Buy | M | 7.31 | 625 | 4,569 | 67,227 | 66.6 K to 67.2 K (+0.94 %) |
| Jan 05 2012 | MDCO | MEDICINES CO /DE | MEANWELL CLIVE | Chairman & CEO | Sell | S | 18.99 | 2,500 | 47,475 | 306,497 | 309 K to 306.5 K (-0.81 %) |
| Dec 21 2011 | MDCO | MEDICINES CO /DE | MEANWELL CLIVE | Chairman & CEO | Sell | S | 20.00 | 2,500 | 50,000 | 308,997 | 311.5 K to 309 K (-0.80 %) |
| Dec 21 2011 | MDCO | MEDICINES CO /DE | SBLENDORIO GLENN | Executive VP & CFO | Option Exercise | M | 7.31 | 625 | 4,569 | 17,500 | |
| Dec 21 2011 | MDCO | MEDICINES CO /DE | SBLENDORIO GLENN | Executive VP & CFO | Sell | S | 19.50 | 625 | 12,188 | 66,602 | 67.2 K to 66.6 K (-0.93 %) |
| Dec 21 2011 | MDCO | MEDICINES CO /DE | SBLENDORIO GLENN | Executive VP & CFO | Buy | M | 7.31 | 625 | 4,569 | 67,227 | 66.6 K to 67.2 K (+0.94 %) |
| Dec 14 2011 | MDCO | MEDICINES CO /DE | MEANWELL CLIVE | Chairman & CEO | Sell | S | 19.20 | 13,965 | 268,128 | 311,497 | 325.5 K to 311.5 K (-4.29 %) |
| Dec 21 2011 | MDCO | MEDICINES CO /DE | O'Connor William Bernard | Chief Accounting Of ... | Sell | S | 20.00 | 2,881 | 57,620 | 14,075 | 17 K to 14.1 K (-16.99 %) |
| Dec 14 2011 | MDCO | MEDICINES CO /DE | Antinori Paul Michael | Sr. VP & General Co ... | Sell | S | 19.46 | 485 | 9,438 | 32,672 | 33.2 K to 32.7 K (-1.46 %) |
| Dec 05 2011 | MDCO | MEDICINES CO /DE | MEANWELL CLIVE | Chairman & CEO | Sell | S | 18.87 | 2,500 | 47,175 | 325,462 | 328 K to 325.5 K (-0.76 %) |
| Nov 22 2011 | MDCO | MEDICINES CO /DE | SBLENDORIO GLENN | Executive VP & CFO | Option Exercise | M | 7.31 | 625 | 4,569 | 18,125 | |
| Nov 22 2011 | MDCO | MEDICINES CO /DE | SBLENDORIO GLENN | Executive VP & CFO | Sell | S | 17.81 | 625 | 11,131 | 66,602 | 67.2 K to 66.6 K (-0.93 %) |
| Nov 22 2011 | MDCO | MEDICINES CO /DE | SBLENDORIO GLENN | Executive VP & CFO | Buy | M | 7.31 | 625 | 4,569 | 67,227 | 66.6 K to 67.2 K (+0.94 %) |
| Nov 16 2011 | MDCO | MEDICINES CO /DE | SBLENDORIO GLENN | Executive VP & CFO | Sell | S | 19.50 | 3,635 | 70,883 | 66,602 | 70.2 K to 66.6 K (-5.18 %) |
| Nov 03 2011 | MDCO | MEDICINES CO /DE | MEANWELL CLIVE | Chairman & CEO | Sell | S | 18.10 | 2,500 | 45,250 | 327,962 | 330.5 K to 328 K (-0.76 %) |
| Oct 21 2011 | MDCO | MEDICINES CO /DE | SBLENDORIO GLENN | Executive VP & CFO | Option Exercise | M | 7.31 | 625 | 4,569 | 18,750 | |
| Oct 21 2011 | MDCO | MEDICINES CO /DE | SBLENDORIO GLENN | Executive VP & CFO | Sell | S | 18.98 | 625 | 11,863 | 70,237 | 70.9 K to 70.2 K (-0.88 %) |
| Oct 21 2011 | MDCO | MEDICINES CO /DE | SBLENDORIO GLENN | Executive VP & CFO | Buy | M | 7.31 | 625 | 4,569 | 70,862 | 70.2 K to 70.9 K (+0.89 %) |
| Oct 05 2011 | MDCO | MEDICINES CO /DE | MEANWELL CLIVE | Chairman & CEO | Sell | S | 17.00 | 2,500 | 42,500 | 330,462 | 333 K to 330.5 K (-0.75 %) |
| Sep 21 2011 | MDCO | MEDICINES CO /DE | SBLENDORIO GLENN | Executive VP & CFO | Option Exercise | M | 7.31 | 625 | 4,569 | 19,375 | |
| Sep 21 2011 | MDCO | MEDICINES CO /DE | SBLENDORIO GLENN | Executive VP & CFO | Sell | S | 15.22 | 625 | 9,513 | 70,237 | 70.9 K to 70.2 K (-0.88 %) |
| Sep 21 2011 | MDCO | MEDICINES CO /DE | SBLENDORIO GLENN | Executive VP & CFO | Buy | M | 7.31 | 625 | 4,569 | 70,862 | 70.2 K to 70.9 K (+0.89 %) |
| Sep 15 2011 | MDCO | MEDICINES CO /DE | SBLENDORIO GLENN | Executive VP & CFO | Option Exercise | M | 7.31 | 25 | 183 | 20,000 | |
| Sep 15 2011 | MDCO | MEDICINES CO /DE | SBLENDORIO GLENN | Executive VP & CFO | Option Exercise | M | 7.31 | 600 | 4,386 | 20,025 | |
| Sep 15 2011 | MDCO | MEDICINES CO /DE | SBLENDORIO GLENN | Executive VP & CFO | Sell | S | 15.00 | 25 | 375 | 70,237 | 70.3 K to 70.2 K (-0.04 %) |
| Sep 15 2011 | MDCO | MEDICINES CO /DE | SBLENDORIO GLENN | Executive VP & CFO | Buy | M | 7.31 | 25 | 183 | 70,262 | 70.2 K to 70.3 K (+0.04 %) |
| Sep 15 2011 | MDCO | MEDICINES CO /DE | SBLENDORIO GLENN | Executive VP & CFO | Sell | S | 15.00 | 600 | 9,000 | 70,237 | 70.8 K to 70.2 K (-0.85 %) |
| Sep 15 2011 | MDCO | MEDICINES CO /DE | SBLENDORIO GLENN | Executive VP & CFO | Buy | M | 7.31 | 600 | 4,386 | 70,837 | 70.2 K to 70.8 K (+0.85 %) |
| Sep 01 2011 | MDCO | MEDICINES CO /DE | SBLENDORIO GLENN | Executive VP & CFO | Buy | J | 12.39 | 404 | 5,006 | 70,237 | 69.8 K to 70.2 K (+0.58 %) |
| Sep 01 2011 | MDCO | MEDICINES CO /DE | MEANWELL CLIVE | Chairman & CEO | Buy | J | 12.39 | 748 | 9,268 | 332,962 | 332.2 K to 333 K (+0.23 %) |
| Jul 21 2011 | MDCO | MEDICINES CO /DE | SBLENDORIO GLENN | Executive VP & CFO | Option Exercise | M | 7.31 | 625 | 4,569 | 20,625 | |
| Jul 21 2011 | MDCO | MEDICINES CO /DE | SBLENDORIO GLENN | Executive VP & CFO | Sell | S | 15.65 | 625 | 9,781 | 69,833 | 70.5 K to 69.8 K (-0.89 %) |
| Jul 21 2011 | MDCO | MEDICINES CO /DE | SBLENDORIO GLENN | Executive VP & CFO | Buy | M | 7.31 | 625 | 4,569 | 70,458 | 69.8 K to 70.5 K (+0.89 %) |
| Jul 08 2011 | MDCO | MEDICINES CO /DE | MEANWELL CLIVE | Chairman & CEO | Sell | S | 17.00 | 2,500 | 42,500 | 332,214 | 334.7 K to 332.2 K (-0.75 %) |
| Jun 22 2011 | MDCO | MEDICINES CO /DE | SBLENDORIO GLENN | Executive VP & CFO | Option Exercise | M | 7.31 | 625 | 4,569 | 21,250 | |
| Jun 22 2011 | MDCO | MEDICINES CO /DE | SBLENDORIO GLENN | Executive VP & CFO | Sell | S | 16.60 | 625 | 10,375 | 69,833 | 70.5 K to 69.8 K (-0.89 %) |
| Jun 22 2011 | MDCO | MEDICINES CO /DE | SBLENDORIO GLENN | Executive VP & CFO | Buy | M | 7.31 | 625 | 4,569 | 70,458 | 69.8 K to 70.5 K (+0.89 %) |
| Jun 03 2011 | MDCO | MEDICINES CO /DE | MEANWELL CLIVE | Chairman & CEO | Sell | S | 19.10 | 2,500 | 47,750 | 334,714 | 337.2 K to 334.7 K (-0.74 %) |
| May 31 2011 | MDCO | MEDICINES CO /DE | CROUSE WILLIAM | Director | Option Exercise | A | 18.18 | 13,259 | 241,049 | 13,259 | |
| May 31 2011 | MDCO | MEDICINES CO /DE | CROUSE WILLIAM | Director | Grant | A | 0.00 | 5,914 | 0 | 20,914 | 15 K to 20.9 K (+39.43 %) |
| May 31 2011 | MDCO | MEDICINES CO /DE | Shigeta Hiroaki | Director | Option Exercise | A | 18.18 | 18,259 | 331,949 | 18,259 | |
| May 31 2011 | MDCO | MEDICINES CO /DE | Shigeta Hiroaki | Director | Grant | A | 0.00 | 5,914 | 0 | 20,914 | 15 K to 20.9 K (+39.43 %) |
| May 31 2011 | MDCO | MEDICINES CO /DE | KESSLER ARMIN M | Director | Option Exercise | A | 18.18 | 13,259 | 241,049 | 13,259 | |
| May 31 2011 | MDCO | MEDICINES CO /DE | KESSLER ARMIN M | Director | Grant | A | 0.00 | 5,914 | 0 | 109,599 | 103.7 K to 109.6 K (+5.70 %) |
| May 31 2011 | MDCO | MEDICINES CO /DE | Spigelman Melvin K | Director | Option Exercise | A | 18.18 | 13,259 | 241,049 | 13,259 | |
| May 31 2011 | MDCO | MEDICINES CO /DE | Spigelman Melvin K | Director | Grant | A | 0.00 | 5,914 | 0 | 20,914 | 15 K to 20.9 K (+39.43 %) |
| May 31 2011 | MDCO | MEDICINES CO /DE | WYATT ELIZABETH H S | Director | Option Exercise | A | 18.18 | 13,259 | 241,049 | 13,259 | |
| May 31 2011 | MDCO | MEDICINES CO /DE | WYATT ELIZABETH H S | Director | Grant | A | 0.00 | 5,914 | 0 | 20,914 | 15 K to 20.9 K (+39.43 %) |
| May 31 2011 | MDCO | MEDICINES CO /DE | Kelly John C. | Director | Option Exercise | A | 18.18 | 13,259 | 241,049 | 13,259 | |
| May 31 2011 | MDCO | MEDICINES CO /DE | Kelly John C. | Director | Grant | A | 0.00 | 5,914 | 0 | 5,914 | 0 to 5.9 K |
| May 31 2011 | MDCO | MEDICINES CO /DE | Savage Robert G. | Director | Option Exercise | A | 18.18 | 13,259 | 241,049 | 13,259 | |
| May 31 2011 | MDCO | MEDICINES CO /DE | Savage Robert G. | Director | Grant | A | 0.00 | 5,914 | 0 | 20,914 | 15 K to 20.9 K (+39.43 %) |
| May 31 2011 | MDCO | MEDICINES CO /DE | HUGIN ROBERT J | Director | Option Exercise | A | 18.18 | 13,259 | 241,049 | 13,259 | |
| May 31 2011 | MDCO | MEDICINES CO /DE | HUGIN ROBERT J | Director | Grant | A | 0.00 | 5,914 | 0 | 39,247 | 33.3 K to 39.2 K (+17.74 %) |
| May 31 2011 | MDCO | MEDICINES CO /DE | SBLENDORIO GLENN | Executive VP & CFO | Sell | S | 19.24 | 3,724 | 71,650 | 69,833 | 73.6 K to 69.8 K (-5.06 %) |
| May 20 2011 | MDCO | MEDICINES CO /DE | SBLENDORIO GLENN | Executive VP & CFO | Option Exercise | M | 7.31 | 625 | 4,569 | 1,250 | |
| May 20 2011 | MDCO | MEDICINES CO /DE | SBLENDORIO GLENN | Executive VP & CFO | Sell | S | 17.13 | 625 | 10,706 | 73,557 | 74.2 K to 73.6 K (-0.84 %) |
| May 20 2011 | MDCO | MEDICINES CO /DE | SBLENDORIO GLENN | Executive VP & CFO | Buy | M | 7.31 | 625 | 4,569 | 74,182 | 73.6 K to 74.2 K (+0.85 %) |
| May 20 2011 | MDCO | MEDICINES CO /DE | SBLENDORIO GLENN | Executive VP & CFO | Sell | S | 17.00 | 1,005 | 17,085 | 73,557 | 74.6 K to 73.6 K (-1.35 %) |
| May 20 2011 | MDCO | MEDICINES CO /DE | MEANWELL CLIVE | Chairman & CEO | Sell | S | 17.00 | 2,500 | 42,500 | 337,214 | 339.7 K to 337.2 K (-0.74 %) |
| May 20 2011 | MDCO | MEDICINES CO /DE | KESSLER ARMIN M | Director | Option Exercise | M | 13.80 | 7,500 | 103,500 | 0 | |
| May 20 2011 | MDCO | MEDICINES CO /DE | KESSLER ARMIN M | Director | Sell | S | 16.92 | 7,500 | 126,900 | 103,685 | 111.2 K to 103.7 K (-6.75 %) |
| May 20 2011 | MDCO | MEDICINES CO /DE | KESSLER ARMIN M | Director | Buy | M | 13.80 | 7,500 | 103,500 | 111,185 | 103.7 K to 111.2 K (+7.23 %) |
| Apr 28 2011 | MDCO | MEDICINES CO /DE | Kelly John C. | Director | Option Exercise | A | 16.08 | 25,000 | 402,000 | 25,000 | |
| Apr 21 2011 | MDCO | MEDICINES CO /DE | SBLENDORIO GLENN | Executive VP & CFO | Option Exercise | M | 7.31 | 625 | 4,569 | 1,250 | |
| Apr 21 2011 | MDCO | MEDICINES CO /DE | SBLENDORIO GLENN | Executive VP & CFO | Sell | S | 16.10 | 625 | 10,063 | 74,562 | 75.2 K to 74.6 K (-0.83 %) |
| Apr 21 2011 | MDCO | MEDICINES CO /DE | SBLENDORIO GLENN | Executive VP & CFO | Buy | M | 7.31 | 625 | 4,569 | 75,187 | 74.6 K to 75.2 K (+0.84 %) |
| Apr 06 2011 | MDCO | MEDICINES CO /DE | Flynn James E | 10% Owner | Sell | S | 16.20 | 24,765 | 401,193 | 3,035,472 | 3.1 M to 3 M (-0.81 %) |
| Apr 06 2011 | MDCO | MEDICINES CO /DE | Flynn James E | 10% Owner | Sell | S | 16.20 | 18,835 | 305,127 | 2,303,811 | 2.3 M to 2.3 M (-0.81 %) |
| Apr 06 2011 | MDCO | MEDICINES CO /DE | Flynn James E | 10% Owner | Sell | S | 16.35 | 3,409 | 55,737 | 3,060,237 | 3.1 M to 3.1 M (-0.11 %) |
| Apr 06 2011 | MDCO | MEDICINES CO /DE | Flynn James E | 10% Owner | Sell | S | 16.35 | 2,591 | 42,363 | 2,322,646 | 2.3 M to 2.3 M (-0.11 %) |
| Apr 06 2011 | MDCO | MEDICINES CO /DE | Flynn James E | 10% Owner | Sell | S | 16.37 | 30,887 | 505,620 | 3,063,646 | 3.1 M to 3.1 M (-1.00 %) |
| Apr 06 2011 | MDCO | MEDICINES CO /DE | Flynn James E | 10% Owner | Sell | S | 16.37 | 23,490 | 384,531 | 2,325,237 | 2.3 M to 2.3 M (-1.00 %) |
| Apr 06 2011 | MDCO | MEDICINES CO /DE | Flynn James E | 10% Owner | Sell | S | 16.39 | 86,166 | 1,412,261 | 3,094,533 | 3.2 M to 3.1 M (-2.71 %) |
| Apr 06 2011 | MDCO | MEDICINES CO /DE | Flynn James E | 10% Owner | Sell | S | 16.39 | 65,534 | 1,074,102 | 2,348,727 | 2.4 M to 2.3 M (-2.71 %) |
| Apr 06 2011 | MDCO | MEDICINES CO /DE | Flynn James E | 10% Owner | Sell | S | 16.36 | 17,259 | 282,357 | 3,180,699 | 3.2 M to 3.2 M (-0.54 %) |
| Apr 06 2011 | MDCO | MEDICINES CO /DE | Flynn James E | 10% Owner | Sell | S | 16.36 | 13,126 | 214,741 | 2,414,261 | 2.4 M to 2.4 M (-0.54 %) |
| Apr 06 2011 | MDCO | MEDICINES CO /DE | Flynn James E | 10% Owner | Sell | S | 16.28 | 14,201 | 231,192 | 3,197,958 | 3.2 M to 3.2 M (-0.44 %) |
| Apr 06 2011 | MDCO | MEDICINES CO /DE | Flynn James E | 10% Owner | Sell | S | 16.28 | 10,799 | 175,808 | 2,427,387 | 2.4 M to 2.4 M (-0.44 %) |
| Apr 06 2011 | MDCO | MEDICINES CO /DE | Flynn James E | 10% Owner | Sell | S | 16.38 | 39,231 | 642,604 | 3,212,159 | 3.3 M to 3.2 M (-1.21 %) |
| Apr 06 2011 | MDCO | MEDICINES CO /DE | Flynn James E | 10% Owner | Sell | S | 16.38 | 29,837 | 488,730 | 2,438,186 | 2.5 M to 2.4 M (-1.21 %) |
| Apr 06 2011 | MDCO | MEDICINES CO /DE | Flynn James E | 10% Owner | Sell | S | 16.37 | 5,681 | 92,998 | 3,251,390 | 3.3 M to 3.3 M (-0.17 %) |
| Apr 06 2011 | MDCO | MEDICINES CO /DE | Flynn James E | 10% Owner | Sell | S | 16.37 | 4,319 | 70,702 | 2,468,023 | 2.5 M to 2.5 M (-0.17 %) |
| Apr 06 2011 | MDCO | MEDICINES CO /DE | Flynn James E | 10% Owner | Sell | S | 16.37 | 6,249 | 102,296 | 3,257,071 | 3.3 M to 3.3 M (-0.19 %) |
| Apr 06 2011 | MDCO | MEDICINES CO /DE | Flynn James E | 10% Owner | Sell | S | 16.37 | 4,751 | 77,774 | 2,472,342 | 2.5 M to 2.5 M (-0.19 %) |
| Apr 06 2011 | MDCO | MEDICINES CO /DE | Flynn James E | 10% Owner | Sell | S | 16.32 | 14,622 | 238,631 | 3,263,320 | 3.3 M to 3.3 M (-0.45 %) |
| Apr 06 2011 | MDCO | MEDICINES CO /DE | Flynn James E | 10% Owner | Sell | S | 16.32 | 11,120 | 181,478 | 2,477,093 | 2.5 M to 2.5 M (-0.45 %) |